Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Independent and combined effects of environmental factors and CYP2C19 polymorphisms on the risk of esophageal squamous cell carcinoma in Fujian Province of China

BMC Medical Genetics201516:15

https://doi.org/10.1186/s12881-015-0156-3

Received: 24 September 2014

Accepted: 18 February 2015

Published: 17 March 2015

Abstract

Background

The purpose of this study was to explore the effects of CYP2C19 gene polymorphisms and various environmental factors and their interactions on the risk of esophageal squamous cell carcinoma (ESCC) in a Chinese Han population.

Methods

A 1:2 frequency-matched case control study of 285 patients and 570 controls was conducted from June 2010 to May 2011 in AnXi of Fujian province, China. Environmental factors were investigated using a self-administered questionnaire and genotypes were determined using polymerase chain reaction restriction fragment length polymorphism based methods. Unconditional logistic regression models were used for statistical evaluation.

Results

Current or former smoking, consumption of pickled vegetables or hot beverages/food, having a first degree relative with ESCC and history of reflux esophagitis were significantly associated with increased ESCC risk, whereas tea drinking and consumption of fresh vegetables and fruits were significantly associated with decreased risk. The CYP2C19*2 GA/AA genotype was significantly more prevalent in ESCC patients and individuals with at least one copy of the CYP2C19*2 A allele had a 3.19-fold increased risk (adjusted 95% confidence interval (CI): 2.21–4.61, P < 0.001) of ESCC compared with those without this allele. We found no significant associations between CYP2C19*3 genotypes and ESCC. The Cyp2C19*2 polymorphism appeared to have a multiplicative joint effect with tea drinking and hot beverage/food consumption (gene–tea drinking: Pinteraction = 0.042; hot beverage/food consumption: Pinteraction = 6.98 × 10−6) and an additive joint effect with pickled vegetable consumption (interaction contrast ratio = 1.96, 95% CI: 0.12–3.80).

Conclusions

Our findings suggest that the CYP2C19*2 polymorphism plays an important role in the development of ESCC in the Chinese population, modified by tea drinking and consumption of pickled vegetables or hot beverages/food. Further studies are warranted to confirm our results.

Keywords

Case–control study Risk factors Genotype Gene–environment interaction

Background

Esophageal squamous cell carcinoma (ESCC), a treatment resistant cancer that can withstand a combination of surgery, chemotherapy and radiotherapy [1], is the fourth most commonly diagnosed cancer and the fourth leading cause of cancer death in China. ESCC occurs through a complex multistage process that may involve a combination of carcinogen exposure and genetic susceptibility. Although smoking, alcohol drinking and prolonged use of wood or charcoal as sources of fuel for cooking and heating (resulting in excessive smoke inhalation) have been demonstrated as lifestyle factors that contribute to the development of the disease [2-4], the DNA sequence variations that confer an additional risk remain largely unknown.

Cytochrome P450 2C19 (CYP2C19) is an important phase I enzyme expressed abundantly in endothelial and smooth muscle cells [5,6]. This enzyme is involved in the metabolism of numerous therapeutic drugs and other xenobiotics, including S-mephenytoin, omeprazole, diazepam, proguanil, propranolol and certain antidepressants [7]. CYP2C19 is also known to be involved in the detoxification or inactivation of potential carcinogens [8] and the bioactivation of certain environmental procarcinogens to produce reactive DNA binding metabolites [9-11]. Therefore, it is conceivable that CYP2C19 gene polymorphisms may play a major role in inter-individual variability in drug response, drug–drug and drug–xenobiotic interactions and susceptibility to chemical-induced diseases.

Several polymorphisms of CYP2C19 are known to be associated with reduced enzyme activity; however, most cases are due to either CYP2C19*2, which is characterized by a point mutation in exon 5 (681G → A, rs4244285), or CYP2C19*3, which has a mutation in exon 4 (636G → A, rs4986893) [12]. The presence of these alleles is considered to be sufficiently predictive for the phenotypes to be inferred from them. Thus, individuals homozygous for CYP2C19*2 or CYP2C19*3 are considered poor metabolizers (PMs), whereas those with at least one CYP2C19*1 allele are classified as extensive metabolizers (EMs) [13]. Despite the biological plausibility of CYP2C19 functional polymorphisms as modulators of susceptibility to cancer, inconsistent findings have appeared in the literature; for example, CYP2C19 PMs have a high incidence of stomach cancer and lung cancer [14], but conversely have a low incidence of bladder cancer [13]. Furthermore, the role of these gene variants in ESCC has not been sufficiently well investigated. Normally, Asian people have a higher incidence of CYP2C19*3 than Caucasians [15,16] and the two mutations CYP2C19*2 and CYP2C19*3 have been shown to account for almost 100% of Asian PM alleles. Therefore, it would be interesting to determine whether the high incidence of ESCC is correlated with a greater frequency of CYP2C19*3 or CYP2C19*2 in the Chinese population.

In the present study, we hypothesized that individuals with the CYP2C19*2 or CYP2C19*3 polymorphism may have a higher risk of ESCC. We also speculated that there should be a synergistic interaction between the effect of environmental factors and that of the genetic variation in the risk of ESCC.

Methods

Ethics statement

This study was approved by the institutional ethical committees of Fujian Medical University. Written informed consent was obtained from all participants before their participation in the study. All investigations performed in this study were conducted in accordance with the guidelines of the 1975 Declaration of Helsinki.

Study population

A 1:2 frequency-matched case control study was performed between June 2010 and May 2011 in AnXi, in the Fujian Province of China. Two hundred and eighty-five patients (168 males and 117 females; mean age 59.67 ± 9.83 years) were diagnosed with histologically confirmed ESCC at AnXi Hospital. Five hundred and seventy cancer-free control subjects (336 males and 234 females; mean age 59.71 ± 9.84 years) were chosen randomly during the same period from among local residents who underwent a routine health check and were free from any known major diseases. Controls were frequency matched with ESCC patients according to sex, age (within 5 years), ethnicity and area of residence. All subjects were genetically unrelated ethnic Han Chinese from AnXi or the surrounding regions.

Data collection

A standard questionnaire was administered to cases and controls by specially trained interviewers. Questions covered demographic characteristics (e.g. age, education level, job, marital status, sex), dietary habits, lifestyle habits such as tobacco smoking and alcohol drinking, personal medical history and family history of cancer. Non-smokers were defined as individuals who had never smoked cigarettes or who had smoked less than 100 cigarettes in lifetime. Ever tea drinking was defined as drinking at least 1 cup of green tea per week for more than 6 months. Ever alcohol drinkers were subjects who had consumed any alcoholic beverage, including beer, wine or distilled spirits, at least once per week for a minimum of 6 months.

Genetic polymorphism genotyping

Blood samples were collected with a standard venepuncture technique and ethylenediaminetetraacetic acid-containing tubes. DNA was extracted from the blood cell pellet using a Blood Genome DNA Extraction Kit (Takara Bio Inc., Ōtsu, Japan) and stored at −20°C. CYP2C19*2 (681G → A, rs4244285) and CYP2C19*3 (636G → A, rs4986893) genotypes were determined using polymerase chain reaction (PCR)-based restriction fragment length polymorphism. PCR was performed with 25 μl of reaction mixture containing 100 ng of DNA, 0.1 mmol/l of each primer, 0.2 mmol/l of deoxynucleoside triphosphate, 1.0 U of Taq DNA polymerase (Takara Bio Inc.), 1 × reaction buffer and 1.5 mmol/l of MgCl2. The PCR profile comprised an initial melting step for 2 min at 95°C, followed by 35 cycles of 30 s at 94°C, 30 s at 58°C and 30 s at 72°C and a final elongation step of 10 min at 72°C. The forward primer 5′-AATTACAACCAGAGCTTGGC-3′ and the reverse primer 5′-TATCACTTTCCATAAAAGCAAG-3′ were used to detect the CYP2C19*2 allele and the PCR products digested with SmaI I (New England Biolabs, Ipswich, MA); the 168 bp PCR products were cut into 117 and 51 bp fragments in the wild type (WT) but not in CYP2C19*2. The forward primer 5′-AAATTGTTTCCAATCATTTAGCT-3′ and the reverse primer 5′-ACTTCAGGGCTTGGTCAATA-3′ were used to detect the CYP2C19*3 allele and the PCR products digested with BamHI (New England Biolabs); the 271 bp PCR products were cut into 175 and 96 bp fragments in the WT but not in CYP2C19*3. The digested PCR products were analyzed on 3% agarose gels and stained with ethidium bromide. Individuals who inherit two mutant CYP2C19 alleles, whether of the same type (*2/*2, *3/*3) or one of each (*2/*3) have a reduced capacity to metabolize CYP2C19 substrates and are considered to be PMs. Individuals who are homozygous (*1/*1) or heterozygous (*1/*2, *1/*3) for the WT CYP2C19*1 allele have an effective enzyme for metabolizing CYP2C19 substrates and are EMs. For quality control, genotyping was performed by laboratory personnel blinded to the case control status and blank controls were included in each plate. In addition, 10% of the samples were randomly selected and genotyped a second time; the concordance was 100%.

Statistical analysis

Differences in the distribution of demographic characteristics and other risk factors for ESCC between patients and controls were tested using the chi-square test for category variables and Student’s t-test for continuous variables. Adjusted odds ratios (ORs) and their 95% confidence intervals (CIs) were calculated to evaluate the associations of lifestyle habits including smoking, alcohol/tea drinking and diet with risk of ESCC. All models were adjusted for age as a continuous variable, sex, education, income, occupation (farmer/other), family history of cancer in first degree relatives and other potential confounding factors. P values for OR trends were calculated using the order of each risk factor category as a categorical variable.

A goodness of fit chi-square test was used to assess whether the genotype distribution of CYP2C19 polymorphisms was in Hardy–Weinberg equilibrium among the control subjects. Associations between CYP2C19 genotypes and ESCC risk were evaluated using unconditional logistic regression with adjustment for potential confounding factors including age, sex, education, income, occupation, family history of cancer, consumption of vegetables, fruits and meat, smoking status (no/yes), alcohol drinking (no/yes) and tea drinking (no/yes).

Stratified analysis was used to explore potential gene–environment interactions. We dichotomized the genetic polymorphisms by grouping subjects into carriers and non-carriers of the risk genotype. Similarly, environmental factors were dichotomized by appropriate grouping. P values for multiplicative interactions were derived from a cross-product term for gene and environmental exposure introduced into a multiplicative model. Interaction contrast ratio (ICR) was used to evaluate potential additive interactions, as follows: ICR = OReg – ORe – ORg + 1, where OReg is the OR for both the genotype and the environmental exposure, ORe is the OR for the environment only and ORg is the OR for the genotype only. For ICR > 0, we concluded that there was a positive additive interaction. Ninety-five percent CIs for ICRs were calculated according to the method of Hosmer [17]; an ICR was considered to be statistically significant at an alpha level 0.05 if its 95% CI did not include zero.

All statistical analyses were performed using R software (version 2.14.1; The R Foundation, Vienna, Austria). Two-sided P values of < 0.05 were considered statistically significant.

Results

Characteristics of the study population

Associations between demographic characteristics and ESCC are shown in Table 1. There were no statistically significant differences between ESCC patients and controls in terms of median age, sex or marital status (all P > 0.05), indicating that the frequency matching was adequate. However, a greater proportion of farmers and a lower education level were observed among the patients compared with the controls (both P < 0.001).
Table 1

ESCC risk factors and ESCC risk in a Chinese population

Characteristics

Cases

Controls

χ 2

P value

No

%

No

%

Sex (Male)

    

0.00

1.000

 Male

168

58.95

336

58.95

  

 Female

117

41.05

234

41.05

  

Age group (years)

    

0.24

0.878

<50

97

34.02

191

33.51

  

≥50

188

65.96

379

66.49

  

Education level

    

13.62

0.001

Below middle school

146

51.23

223

39.12

  

middle school

105

36.84

284

49.82

  

High school or higher

34

11.93

63

11.05

  

Marital status

    

2.02

0.365

Marriage

259

90.88

518

90.88

  

Single

26

9.12

52

9.12

  

Job

    

22.54

2.5 × 10-6

 Farmer

235

82.46

382

67.02

  

 Non-farmer

50

17.54

188

32.98

  

Household income, RMB/Month

    

0.71

0.339

<1000

180

63.16

243

42.63

  

>1000

105

36.84

227

39.82

  

Associations between risk factors and ESCC risk

Table 2 shows adjusted associations between risk factors and risk of ESCC. Increased ESCC risk was associated with smoking, number of pack-years of cigarettes smoked, consumption of pickled vegetables, consumption of hot beverages/food, having a first degree relative with ESCC and having a history of reflux esophagitis. Decreased risk of ESCC was associated with tea drinking and consumption of fresh vegetables and fruits. Thus, a total of six environmental factors were selected for evaluation of their interactions with genetic variants in the risk of ESCC.
Table 2

Association between lifestyle and dietary habits and ESCC risk

Variables

Cases

Controls

P a

Adjusted OR

No

%

No

%

(95% CI) b

Smoking1

    

0.042

 

No

130

45.61

281

49.30

 

Reference

Yes

155

54.39

289

50.70

0.194

2.02 (1.10 ~ 3.71)

Pack-years of smoking1

      

Non-smoker

130

45.61

281

49.30

 

Reference

<30

56

19.65

124

21.75

0.814

1.54 (0.80 ~ 2.94)

>30

99

34.74

165

28.95

0.034

1.97 (1.05 ~ 3.68)

Alcohol drinking2

    

0.013

 

No

220

77.19

451

79.12

 

Reference

Yes

65

22.81

119

20.88

 

1.09 (0.70 ~ 1.57)

Tea drinking3

    

2.99 × 10-9

 

No

156

54.74

277

48.60

  

Yes

129

45.26

293

51.40

 

0.63 (0.45 ~ 0.91)

Hot beverage/food intake4

    

5.74 × 10-5

 

No

111

38.95

359

62.98

 

Reference

Yes

174

61.05

211

37.02

 

2.95 (2.06~4.22)

Pickled vegetables5

      

No

135

47.37

355

62.28

5.47 × 10-5

Reference

Yes

150

52.63

215

37.72

 

1.87 (1.38~2.55)

Fresh vegetables and fruits (g/day)6

    

0.341

 

<400

277

97.19

507

88.95

 

Reference

≥400

8

2.81

63

11.05

 

0.20 (0.10 ~ 0.44)

Meat (g/day)7

    

0.016

 

<200

267

93.68

507

88.95

 

Reference

≥200

18

6.32

18

3.16

 

0.75 (0.42 ~ 1.35)

Family history of ESCC8

    

0.025

 

No

241

84.56

523

91.75

 

Reference

Yes

44

15.44

47

8.25

 

1.77 (1.11 ~ 2.80)

History of reflux esophagitis9

   

0.026

  

No

274

96.14

562

98.60

 

Reference

Yes

11

3.86

8

1.40

 

2.96 (1.14 ~ 7.67)

aP value based on the Wald test.

bOdds ratio (OR) was determined using logistic regression and age, sex, education, income, marital status, tea drinking, alcohol drinking, smoking, pickled vegetables, fresh vegetables and fruits, meat, family history of ESCC, history of reflux esophagitis and hot beverage/food intake were included in the multivariate models.

Association between CYP2C19 polymorphisms and ESCC risk

Single nucleotide polymorphism (SNP) data, observed allele frequencies and Hardy–Weinberg test results are presented in Table 3. In the control group, the frequencies of the CYP2C19*2 A and CYP2C19*3 A alleles were 0.335 and 0.054, respectively, and were in Hardy–Weinberg equilibrium (both P > 0.05). On single allelic analysis, tests for association between ESSC and the two SNPs showed a significant difference only for CYP2C19*2 (G681A); the association remained significant after multiple comparison correction by permutation tests (P < 0.05; Table 3). The findings for each of the two SNP genotypes according to risk of ESCC are shown in Table 4 along with their adjusted ORs. The frequencies of the CYP2C19*2 GG, GA and AA genotypes in the ESCC patients differed significantly from those in the control group (χ2 = 43.56, P < 0.001, degrees of freedom = 2), with GA and AA being more frequent in patients than in controls. The homozygous mutant genotype (AA) of CYP2C19*3 was not detected in any subject, patient or control, and the frequencies of the CYP2C19*3 GG and GA genotypes did not differ significantly between the controls and patients.
Table 3

SNPs identified for CYP2C19

Nomenclature

SNP

Nucleotide changes

Effect

MAF a

P value for HWF in Controls

NCBI b

Controls

Cases

P value for association analysis c

CYP2C19*2 (exon5)

rs4244285

G681A

Splicing defect

0.256

0.335

0.488

2.31 × 10-5

0.09

CYP2C19*3 (exon4)

rs4986893

G636A

W212X

0.058

0.054

0.040

0.053

0.177

HWE: Hardy–Weinberg equilibrium; MAF: minor allele frequency.

aMajor/minor allele.

bMAF for Chinese in the NCBI dbSNPs database. (http://www.ncbi.nlm.nih.gov/SNP).

cAfter correcting for multiple testing by Haploview software using 1000 permutations.

Table 4

Association between CYP2C19 genotype and risk of ESCC

Polymorphism. ID no

Genotypes

Cases n (%)

Controls n (%)

Crude OR (95% CI)

Adjusted OR (95% CI a )

P -value a,b

CYP2C19*2

      

rs4244285

GG

59 (20.70)

243 (42.63)

1.00 (Reference)

1.00 (Reference)

6.47 × 10-8

 

GA

174 (61.05)

272 (47.72)

2.64 (1.87 ~ 3.71)

2.91 (1.99 ~ 4.25)

4.46 × 10-7

 

AA

52 (18.25)

55 (9.65)

3.89 (2.42 ~ 6.26)

4.82 (2.84 ~ 8.17)

1.21 × 10-6

 

GA + AA

226 (79.30)

327 (57.37)

2.85 (2.04 ~ 3.96)

3.19 (2.21 ~ 4.61)

2.16 × 10-8

Test for trend

   

2.08 (1.66 ~ 2.61)

2.30 (1.79 ~ 2.97)

3.17 × 10-8

CYP2C19*3

      

rs4986893

GG

262 (91.93)

509 (89.30)

1.00 (Reference)

1.00 (Reference)

0.236

 

GA

23 (8.07)

61 (10.70)

0.73 (0.44 ~ 1.21)

0.72 (0.422 ~ 1.24)

 

EMs

*2/*2,*2/*3

226 (79.30)

491 (86.14)

1.00 (Reference)

1.00 (Reference)

0.009

PMs

*1/*1, *1/*2, *1/*3

59 (20.70)

79 (13.86)

1.62 (1.12 ~ 2.35)

1.71 (1.14 ~ 2.57)

 

n: number of individuals; OR, odds ratio; CI: confidence interval.

aAdjusted for sex, age, education, income, smoking, tea drinking, body mass index and other variables.

bP value based on the Wald test.

Unconditional logistic regression analysis was used to evaluate associations between the genotypes of the two CYP2C19 polymorphisms and risk of ESCC. After adjustment for age, sex, income, marital status, education, smoking, tea drinking and other variables, a significant risk effect for ESCC was found to be associated with the CYP2C19*2 genotype. Specifically, compared with homozygous GG subjects, carriers of the heterozygous GA and homozygous AA genotypes had a significantly increased risk of ESCC (adjusted OR = 2.91, 95% CI: 1.99–4.25 for GA; adjusted OR = 4.82, 95% CI: 2.84–8.17 for AA) in an allelic dose–response manner (adjusted PTrend = 0.000). On pooled analysis, we found that individuals with at least one copy of the CYP2C19*2 A allele had a 3.19-fold increased risk (adjusted 95% CI: 2.21–4.61, P < 0.001) of ESCC compared with those without this allele. We found no significant associations between the CYP2C19*3 genotype and ESCC in multivariate logistic regression models.

The association between being a CYP2C19 PM and having ESCC was further analyzed. The frequency of CYP2C19 PMs (the genotypes *2/*2 and *2/*3 but not *3/*3 were found in this study) was significantly higher among the ESCC patients than in the control group (20.70% vs 13.86%). After adjustment for age, sex, income, marital status, education, smoking, tea drinking and other variables, CYP2C19 PMs had a 1.71-fold increased risk of ESCC compared with EMs.

Possible interactions between CYP2C19 polymorphisms and environmental factors in ESCC risk

We also explored the combined effects of the CYP2C19*2 polymorphism and certain environmental factors on the risk of ESCC (Table 5). No significant interactions (multiplicative or additive) between CYP2C19*2 and alcohol drinking, smoking or consumption of fresh vegetables and fruits were observed. However, the CYP2C19*2 polymorphism appeared to have a multiplicative joint effect with tea drinking and hot beverage/food consumption (gene–tea drinking: Pinteraction = 0.042; hot beverage/food consumption: Pinteraction = 6.98 × 10−6) and an additive joint effect with pickled vegetable consumption (ICR = 1.96, 95% CI: 0.12–3.80). Specifically, tea drinking may decrease the effect of the GA/AA genotype on ESCC risk. By contrast, consumption of hot beverages/food or pickled vegetables may increase the risk effect of the GA/AA genotype.
Table 5

Combined effects of CYP2C19 polymorphism and environmental factors

Exposure

CYP2C19*2

Patients n (%)

Controls n (%)

Adjusted OR (95% CI) a

P value for multiplicative interaction a

ICR (95% CI) a

Tea drinking

   

0.04

-1.77 (-3.92 ~ 0.38)

Never

GG

25 (8.77)

136 (23.86)

Reference

  

Never

GA/AA

104 (36.49)

157 (27.54)

4.17 (2.46 ~ 7.08)

  

Ever

GG

34 (11.93)

107 (18.77)

0.52 (0.32 ~ 0.84)

  

Ever

GA/AA

122 (42.81)

170 (29.82)

1.92 (1.41 ~ 2.63)

  

Alcohol drinking

   

0.051

-1.79 (-4.04 ~ 0.46)

Never

GG

40 (14.04)

197 (34.56)

Reference

  

Never

GA/AA

180 (63.16)

254 (44.56)

3.63 (2.39 ~ 5.51)

  

Ever

GG

19 (6.67)

46 (8.07)

2.32 (1.15 ~ 4.71)

  

Ever

GA/AA

46 (16.14)

73 (12.81)

2.86 (1.60 ~ 5.10)

  

Smoking

    

0.48

1.180 (-1.21 ~ 3.57)

Never

GG

30 (10.53)

134 (23.51)

Reference

  

Never

GA/AA

100 (35.09)

147 (25.79)

3.41 (2.09 ~ 5.57)

  

Ever

GG

29 (10.18)

109 (19.12)

2.23 (1.01 ~ 4.94)

  

Ever

GA/AA

126 (44.21)

180 (31.58)

5.82 (2.80 ~ 12.09)

  

Intake of fresh fruits and vegetables (g/day)

   

0.10

1.92 (-5.15 ~ 1.31)

<400

GG

55 (19.30)

212 (37.19)

Reference

  

<400

GA/AA

222 (77.89)

295 (51.75)

2.94 (2.04 ~ 4.24)

  

≥400

GG

4 (1.40)

31 (5.44)

0.41 (0.134 ~ 1.27)

  

≥400

GA/AA

4 (1.40)

32 (5.61)

0.43 (0.14 ~ 1.33)

  

Pickled vegetables

   

0.12

1.96 (0.12 ~ 3.80)

Never

GG

32 (11.23)

150 (26.32)

Reference

  

Never

GA/AA

103 (36.14)

205 (35.96)

2.55 (1.61 ~ 4.06)

  

Ever

GG

27 (9.47)

93 (16.32)

1.66 (0.90 ~ 3.04)

  

Ever

GA/AA

123 (43.16)

122 (21.40)

5.17 (3.21 ~ 8.33)

  

Hot Beverage and food intake

  

6.98 × 10-6

-0.66 (-6.42 ~ 5.10)

Never

GG

12 (4.21)

167 (29.30)

Reference

  

Never

GA/AA

99 (34.74)

192 (33.68)

7.64 (3.90 ~ 14.94)

  

Ever

GG

47 (16.49)

76 (13.33)

9.87 (4.67 ~ 20.85)

  

Ever

GA/AA

127 (44.56)

135 (23.68)

15.85 (7.78 ~ 32.30)

  

aAdjusted for age, sex, education, income, job, marital status, family history of cancer in first degree relatives and other potential confounding factors.

Discussion

ESCC is prevalent among the Chinese population, with marked regional variations in incidence and mortality. Although the pathogenesis of ESCC is not fully elucidated, accumulative epidemiologic evidence has shown that genetic and environmental factors play crucial roles in its etiology. In the present study, we conducted a case control study to examine the role of the two most common functional variants of the CYP2C19 gene (CYP2C19*2 and CYP2C19*3) in the development of ESCC in a Chinese population, including the effects of environmental risk factors. We found CYP2C19*2 to be the more common locus in the Chinese population, and multivariable logistic analysis revealed that the presence of the CYP2C19*2 A allele (AA or AG genotype) increased the risk of ESCC. Most of the established risk factors for ESCC evaluated in the present study had strong associations with ESCC risk. Generally in case control studies, a potential gene–environment interaction is assessed; our results show that the association between the CYP2C19*2 A variant and ESCC was modified by tea drinking and consumption of pickled vegetables or hot beverages/food. These findings suggest that CYP2C19 is involved in the detoxification of certain carcinogens involved in the development of ESCC. To our knowledge, this is the first study to report this gene–environment interaction between environmental factors and the CYP2C19*2 polymorphism with respect to the risk of ESCC in a Chinese population.

CYP2C19, one of the most important cytochrome P450s, is a key enzyme that is not only responsible for the metabolism of numerous therapeutic drugs [17-20] but is also suspected to play a major role in the detoxification or inactivation of potential carcinogens and the bioactivation of certain environmental procarcinogens to produce toxic DNA binding metabolites [8,21]. Therefore, CYP2C19 is considered an important defense against cancer. The human CYP2C19 gene is highly polymorphic; the most important alleles are CYP2C19*2 (681G → A, rs4244285) and CYP2C19*3 (636G → A, rs4986893). The nucleotide changes in CYP2C19*2 and *3 lead to a splicing defect and a stop codon, respectively, and thereby to nonfunctional proteins and the PM phenotype [22]. The two main enzyme-deficient alleles of CYP2C19 are suspected to be associated with susceptibility to cancer, though several studies concerning CYP2C19 polymorphism and cancer susceptibility among various populations have reported inconsistent results [23-26]. In the present study, we found the frequency of CYP2C19*2 to be higher than that of CYP2C19*3 in Chinese Han subjects and the PM genotype was associated with an increased risk of ESCC. This finding is consistent with a recent meta-analysis by Wang et al. [14], who found an association between the CYP2C19 PM genotype and increased risk of esophageal cancer (PM vs EM: OR = 2.93, 95% CI: 2.06–4.17) among 308 cases and 644 controls. However, our single-locus analysis found a significantly elevated risk of ESCC for the CYP2C19*2 allele but not for CYP2C19*3. Subjects carrying the CYP2C19*2 A allele (AA or GA genotype) had a higher risk of ESCC than GG and patients carrying at least one variant allele had a 3.19-fold increased risk of developing ESCC. CYP2C19*3 has a premature stop codon in exon 4 and it is biologically plausible that the CYP2C19*3 polymorphism is a modulator of cancer susceptibility; however, we did not find CYP2C19*3 to be associated with ESCC susceptibility in our study population. This finding is inconsistent with a recent report from Shi et al. [27], who found that the frequency of the CYP2C19*3 A allele was significantly higher in ESCC patients than in controls (5.57% vs 1.86%, P = 0.004). Our current understanding of carcinogenesis indicates a multifactorial and multistep process involving various genetic alterations and environmental factors and it is unlikely that risk factors for cancer act in isolation from each other. Therefore, differences in certain environmental factors may have contributed to this discrepancy. For example, Shi et al. [27] found that alcohol drinking was a risk factor for ESCC, whereas in the present study we did not find alcohol to be associated with ESCC. More importantly, the genetic effects of a SNP may depend on its interactions with environmental factors. Therefore, additional studies with a much larger sample size are warranted to confirm our results. Despite much investigation, the details of the role of environmental factors and pathogenic mechanisms in cancer remain a matter of speculation.

CYP2C19 polymorphism is considered to be one of the factors that determine an individual’s susceptibility cancer through variations in ability to detoxify carcinogens and/or activate procarcinogens [28,29]. CYP2C19 PM status interacts significantly with environmental risk factors in modifying susceptibility to squamous cell carcinoma of the head and neck [30]. To explore the gene–environment interaction in ESCC, we investigated the effects of the CYP2C192 gene and environmental factors on ESCC risk. Our findings suggest that the CYP2C19*2 polymorphism has a multiplicative joint effect with tea drinking and hot beverage/food consumption and an additive joint effect with pickled vegetable consumption. Specifically, consumption of hot beverages/food or pickled vegetables may increase the risk effect of the GA/AA genotype in ESCC. By contrast, tea drinking may decrease the risk effect of the GA/AA genotype.

Ecologic studies have shown higher risks of esophageal and gastric cancers in areas where the consumption of pickled food is high [31,32]. Consistent with this, our data show that pickled food consumption was associated with a 1.76-fold increased risk of ESCC compared with subjects who did not consume pickled food, and this association was modified by the presence of CYP2C19*2. In individuals carrying the CYP2C19*2 GA/AA genotype, the risk of ESCC in those who consumed picked vegetables was almost twofold greater than that of those who did not. The mechanisms by which pickled vegetables and the CYP2C19*2 polymorphism interact to influence the development of ESCC are unknown; however, previous studies have shown that the traditional method of preparing pickles by packing moist vegetables in jars for weeks or months allows fermentation and growth of fungi and yeasts [33,34] and can potentially yield carcinogenic substances such as N-nitroso compounds and mycotoxins [35-37]. Furthermore, polymorphisms in CYP2C19 largely account for PM status and influence metabolism, particularly detoxification of carcinogens [38]. Therefore, synergism between the CYP2C19*2 polymorphism and pickled vegetable consumption may be expected.

Numerous experimental and clinical studies have suggested that drinking beverages at high temperatures is a cause of esophageal cancer [39,40]. More tumors were observed and the size of esophageal papillomas was increased at temperatures of 70°C and above in a previous experimental study [41]. Consistent with this, our data show that drinking beverages at high temperatures was a risk factor for ESCC. Notably, we found significant synergism between consumption of hot beverages/food and the CYP2C19*2 polymorphism. The mechanisms by which drinking beverages at high temperatures and the CYP2C19*2 polymorphism interact to influence the development of ESCC are unknown and additional studies are warranted to explain and confirm this preliminary evidence.

The results of the present study also suggest possible interactions between tea drinking and the CYP2C19*2 polymorphism. Among individuals with the CYP2C19*2 GA/AA genotype, the risk of ESCC in tea non-drinkers was almost twice that in tea drinkers. Polyphenols in tea possess potent antioxidant and anti-inflammatory properties and modulate several signaling pathways, and these biochemical features are responsible for tea’s anticancer properties [42,43]. Previous studies have reported that green tea protects against cancers caused by various environmental carcinogens [43-45]. CYP2C19 is involved in the metabolism of many carcinogens; therefore, our results suggest that consumption of tea might have a potential ESCC prevention benefit in individuals with the CYP2C19*2 GA/AA genotype. Intervention trials are needed to provide more convincing evidence.

The potential limitations of the present study should be considered. First, this was a hospital-based case control study and selection bias may exist because the control subjects were recruited from a healthy population undergoing an examination, which may not accurately represent a geographically matched population with exposure to similar environmental factors. However, the control subjects came from the same region as the patients and were sampled randomly, which may have reduced the selection bias. Second, recall bias is inevitable in case control studies. However, this would not affect the genotype data and is therefore of less concern in the study of gene–disease associations. Finally, the selected CYP2C19 polymorphism is a single example that was previously reported to have potential functional significance. Further studies of additional SNPs of functional significance are warranted to identify the role of CYP2C19 polymorphism and gene–environment interactions in esophageal carcinogenesis.

Conclusions

In summary, our findings suggest that the CYP2C19*2 A allele (AA or AG genotype) plays an important role in the development of ESCC in the Chinese population. In addition, our results show that the association between the CYP2C19*2 A variant and ESCC was modified by tea drinking and consumption of pickled vegetables or hot beverages/food. Since our study has limited sample size, further studies in a large population are needed to confirm these findings.

Declarations

Acknowledgments

This work was supported by grants from the Program for Outstanding Young Talents of Scientific Research in University of Fujian Province, China (No. JA11106), the National Natural Science Foundation of China (No. 81473047), the Key Program of Scientific Research of Fujian Medical University (09ZD004), and the Foundation of Fujian Province Key Laboratory of Environment and Health (201405).

Authors’ Affiliations

(1)
Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University
(2)
Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Research Center of Molecular Medicine, Fujian Medical University
(3)
CDC of XiaMen

References

  1. Shimada H, Kitabayashi H, Nabeya Y, Okazumi S, Matsubara H, Funami Y, et al. Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery. 2003;133:24–31.View ArticlePubMedGoogle Scholar
  2. Yuan JM, Knezevich AD, Wang R, Gao YT, Hecht SS, Stepanov I. Urinary levels of the tobacco-specific carcinogen N’-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers. Carcinogenesis. 2011;32:1366–71.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Zheng S, Vuitton L, Sheyhidin I, Vuitton DA, Zhang Y, Lu X. Northwestern China: a place to learn more on oesophageal cancer. Part one: behavioural and environmental risk factors. Eur J Gastroenterol Hepatol. 2010;22:917–25.View ArticlePubMedGoogle Scholar
  4. De Stefani E, Deneo-Pellegrini H, Ronco AL, Boffetta P, Correa P, Aune D, et al. Meat consumption, cooking methods, mutagens, and risk of squamous cell carcinoma of the esophagus: a case–control study in Uruguay. Nutr Cancer. 2012;64:294–9.View ArticlePubMedGoogle Scholar
  5. Imig JD, Pham BT, LeBlanc EA, Reddy KM, Falck JR, Inscho EW. Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses. Hypertension. 2000;35:307–12.View ArticlePubMedGoogle Scholar
  6. Ercan B, Ayaz L, Cicek D, Tamer L. Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis. Cell Biochem Funct. 2008;26:309–13.View ArticlePubMedGoogle Scholar
  7. Rendic SP, Guengerich FP: Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Chemicals. Chem Res Toxicol 2014, Dec 8 [Epub ahead of print].Google Scholar
  8. Ellison CA, Tian Y, Knaak JB, Kostyniak PJ, Olson JR. Human hepatic cytochrome P450-specific metabolism of the organophosphorus pesticides methyl parathion and diazinon. Drug Metab Dispos. 2012;40:1–5.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Fujita K, Kamataki T. Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase. Environ Mol Mutagen. 2001;38:339–46.View ArticlePubMedGoogle Scholar
  10. Yamazaki Y, Fujita K, Nakayama K, Suzuki A, Nakamura K, Yamazaki H, et al. Establishment of ten strains of genetically engineered Salmonella typhimurium TA1538 each co-expressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase sensitive to various promutagens. Mutat Res. 2004;562:151–62.View ArticlePubMedGoogle Scholar
  11. Jeurissen SM, Bogaards JJ, Boersma MG, ter Horst JP, Awad HM, Fiamegos YC, et al. Human cytochrome p450 enzymes of importance for the bioactivation of methyleugenol to the proximate carcinogen 1′-hydroxymethyleugenol. Chem Res Toxicol. 2006;19:111–6.View ArticlePubMedGoogle Scholar
  12. de Morais SM, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem. 1994;269:15419–22.PubMedGoogle Scholar
  13. Shi WX, Chen SQ. Frequencies of poor metabolizers of cytochrome P450 2C19 in esophagus cancer, stomach cancer, lung cancer and bladder cancer in Chinese population. World J Gastroenterol. 2004;10:1961–3.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Wang H, Song K, Chen Z, Yu Y. Poor metabolizers at the cytochrome P450 2C19 loci is at increased risk of developing cancer in Asian populations. PLoS One. 2013;8:e73126.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Kurose K, Sugiyama E, Saito Y. Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development. Drug Metab Pharmacokinet. 2012;27:9–54.View ArticlePubMedGoogle Scholar
  16. Kubota T, Chiba K, Ishizaki T. Genotyping of S-mephenytoin 4′-hydroxylation in an extended Japanese population. Clin Pharmacol Ther. 1996;60:661–6.View ArticlePubMedGoogle Scholar
  17. Furuta T, Shirai N, Sugimoto M, Ohashi K, Ishizaki T. Pharmacogenomics of proton pump inhibitors. Pharmacogenomics. 2004;5:181–202.View ArticlePubMedGoogle Scholar
  18. Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, et al. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med. 2009;360:354–62.View ArticlePubMedGoogle Scholar
  19. Desta Z, Zhao X, Shin JG, Flockhart DA. Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin Pharmacokinet. 2002;41:913–58.View ArticlePubMedGoogle Scholar
  20. Rodriguez Arcas MJ, Garcia-Jimenez E, Martinez-Martinez F, Conesa-Zamora P. Role of CYP450 in pharmacokinetics and pharmacogenetics of antihypertensive drugs. Farm Hosp. 2011;35:84–92.View ArticlePubMedGoogle Scholar
  21. Fujita K, Kamataki T. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase. Mutat Res. 2001;483:35–41.View ArticlePubMedGoogle Scholar
  22. Pirmohamed M, Park BK. Genetic susceptibility to adverse drug reactions. Trends Pharmacol Sci. 2001;22:298–305.View ArticlePubMedGoogle Scholar
  23. Yan F, Xu JF, Liu XF, Li XH. Interaction between smoking and CYP2C19*3 polymorphism increased risk of lung cancer in a Chinese population. Tumour Biol. 2014;35:5295–8.View ArticlePubMedGoogle Scholar
  24. Liang S, Hu J, Cao W, Cai S. Meta-analysis of cytochrome P-450 2C9 polymorphism and colorectal cancer risk. PLoS One. 2012;7:e49134.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Zhou B, Song Z, Qian M, Li L, Gong J, Zou S. Functional polymorphisms in the CYP2C19 gene contribute to digestive system cancer risk: evidence from 11,042 subjects. PLoS One. 2013;8:e66865.View ArticlePubMedPubMed CentralGoogle Scholar
  26. Isomura Y, Yamaji Y, Ohta M, Seto M, Asaoka Y, Tanaka Y, et al. A genetic polymorphism of CYP2C19 is associated with susceptibility to biliary tract cancer. J Gastroenterol. 2010;45:1045–52.View ArticlePubMedGoogle Scholar
  27. Shi Y, Luo GJ, Zhang L, Shi J, Zhang DQ, Chen JM, et al. Interaction between alcohol consumption and CYP 2C19 gene polymorphism in relation to oesophageal squamous cell carcinoma. PLoS One. 2012;7:e43412.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Suzuki S, Muroishi Y, Nakanishi I, Oda Y. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer. J Gastroenterol. 2004;39:220–30.View ArticlePubMedGoogle Scholar
  29. Wu MS, Chen CJ, Lin MT, Wang HP, Shun CT, Sheu JC, et al. Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan. Int J Colorectal Dis. 2002;17:338–43.View ArticlePubMedGoogle Scholar
  30. Yadav SS, Ruwali M, Pant MC, Shukla P, Singh RL, Parmar D. Interaction of drug metabolizing cytochrome P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19 genotypes modify the susceptibility to head and neck cancer and treatment response. Mutat Res. 2010;684:49–55.View ArticlePubMedGoogle Scholar
  31. Ren JS, Kamangar F, Forman D, Islami F. Pickled food and risk of gastric cancer–a systematic review and meta-analysis of English and Chinese literature. Cancer Epidemiol Biomarkers Prev. 2012;21:905–15.View ArticlePubMedGoogle Scholar
  32. Song Q, Wang X, Yu IT, Huang C, Zhou X, Li J, et al. Processed food consumption and risk of esophageal squamous cell carcinoma: A case–control study in a high risk area. Cancer Sci. 2012;103:2007–11.View ArticlePubMedGoogle Scholar
  33. Yang CS. Research on esophageal cancer in China: a review. Cancer Res. 1980;40:2633–44.PubMedGoogle Scholar
  34. Vainio H, Heseltine E, Wilbourn J. Report on an IARC working group meeting on some naturally occurring substances. Int J Cancer. 1993;53:535–7.View ArticlePubMedGoogle Scholar
  35. Cheng SJ, Sala M, Li MH, Courtois I, Chouroulinkov I. Promoting effect of Roussin’s red identified in pickled vegetables from Linxian China. Carcinogenesis. 1981;2:313–9.View ArticlePubMedGoogle Scholar
  36. Zhang WX, Xu MS, Wang GH, Wang MY. Quantitative analysis of Roussin red methyl ester in pickled vegetables. Cancer Res. 1983;43:339–41.PubMedGoogle Scholar
  37. Cheng SJ. Mutagenic effect of ether extract of pickled vegetables from Linxian County. Zhonghua Zhong Liu Za Zhi. 1983;5:98–100.PubMedGoogle Scholar
  38. Kappers WA, Edwards RJ, Murray S, Boobis AR. Diazinon is activated by CYP2C19 in human liver. Toxicol Appl Pharmacol. 2001;177:68–76.View ArticlePubMedGoogle Scholar
  39. Tang L, Xu F, Zhang T, Lei J, Binns CW, Lee AH. High temperature of food and beverage intake increases the risk of oesophageal cancer in Xinjiang, China. Asian Pac J Cancer Prev. 2013;14:5085–8.View ArticlePubMedGoogle Scholar
  40. Islami F, Boffetta P, Ren JS, Pedoeim L, Khatib D, Kamangar F. High-temperature beverages and foods and esophageal cancer risk–a systematic review. Int J Cancer. 2009;125:491–524.View ArticlePubMedPubMed CentralGoogle Scholar
  41. Li ZG, Shimada Y, Sato F, Maeda M, Itami A, Kaganoi J, et al. Promotion effects of hot water on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats. Oncol Rep. 2003;10:421–6.PubMedGoogle Scholar
  42. Darvesh AS, Bishayee A. Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer. Nutr Cancer. 2013;65:329–44.View ArticlePubMedGoogle Scholar
  43. Rathore K, Choudhary S, Odoi A, Wang HC. Green tea catechin intervention of reactive oxygen species-mediated ERK pathway activation and chronically induced breast cell carcinogenesis. Carcinogenesis. 2012;33:174–83.View ArticlePubMedGoogle Scholar
  44. Rathore K, Wang HC. Green tea catechin extract in intervention of chronic breast cell carcinogenesis induced by environmental carcinogens. Mol Carcinog. 2012;51:280–9.View ArticlePubMedGoogle Scholar
  45. Chung FL. The prevention of lung cancer induced by a tobacco-specific carcinogen in rodents by green and black Tea. Proc Soc Exp Biol Med. 1999;220:244–8.View ArticlePubMedGoogle Scholar

Copyright

© Peng et al.; licensee BioMed Central. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.